                         SEQUENCE LISTING

<110>  Vaccibody AS
 
<120>  Methods for pre-selection of neoepitopes

<130>  P5263PC00

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  93
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Gln Val Ser Thr Ala Ala Leu Ala Val Leu Leu Cys Thr Met Ala 
1               5                   10                  15      


Leu Cys Asn Gln Val Leu Ser Ala Pro Leu Ala Ala Asp Thr Pro Thr 
            20                  25                  30          


Ala Cys Cys Phe Ser Tyr Thr Ser Arg Gln Ile Pro Gln Asn Phe Ile 
        35                  40                  45              


Ala Asp Tyr Phe Glu Thr Ser Ser Gln Cys Ser Lys Pro Ser Val Ile 
    50                  55                  60                  


Phe Leu Thr Lys Arg Gly Arg Gln Val Cys Ala Asp Pro Ser Glu Glu 
65                  70                  75                  80  


Trp Val Gln Lys Tyr Val Ser Asp Leu Glu Leu Ser Ala 
                85                  90              


<210>  2
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Linkers


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  linker

<400>  2

Gly Gly Gly Gly Ser 
1               5   


<210>  3
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Linkers


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  linker

<400>  3

Gly Gly Gly Ser Gly 
1               5   


<210>  4
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Linkers


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  linker

<400>  4

Gly Gly Gly Gly Ser 
1               5   


<210>  5
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Linkers


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  linker

<400>  5

Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
1               5                   10  


